Item 7.01. Regulation FD Disclosure.

Investor Conference

The officers of Inogen, Inc. (the "Company") will participate in the 2021 J.P. Morgan Healthcare Conference, which begins on Monday, January 11, 2021 at 8:00 a.m. PT. The chief executive officer and chief financial officer are scheduled to present at the conference on Tuesday, January 12, 2021 at 2:20 p.m. PT. During the conference and in separate sessions with analysts and investors, the Company's officers will refer to an updated slide presentation. A copy of this updated slide presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Included in this updated slide presentation is an updated inside sales representative headcount of 300 as of December 31, 2020. Interested parties can access the live audio webcast of this conference presentation from the Events section of the Investor Relations page on the Company's website at www.inogen.com.

The information furnished pursuant to this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the "Securities Act") or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits



Exhibit   Description
 99.1       Investor Presentation
  104     The cover page of this Current Report on Form 8-K, formatted in Inline XBRL

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses